Indefinite Delivery Contract SPE2DB25D9318

The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, which runs through December 31, 2025, covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military health facilities worldwide.

Under this IDC, DMS Pharmaceutical Group will provide both routine and critical medications to fulfill the diverse medical requirements of the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract encompasses a comprehensive array of pharmaceutical items, from common medications like antibiotics and pain relievers to specialized drugs such as oncology treatments, contraceptives, and specialty medications. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.